Prosight Management »

Privia Health Group shares owned by Prosight Management

Quarter-by-quarter ownership of Privia Health Group (PRVA) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Privia Health Group

Tip: Access up to 7 years of quarterly data

All positions including Privia Health Group held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Privia Health Group by Prosight Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $882k 45k 19.59

More positions owned by Prosight Management

Shattuck Labs (STTK)
Adc Therapeutics Sa SHS (ADCT)
Galapagos Nv Spon Adr (GLPG)
Meiragtx Holdings (MGTX)
Kura Oncology (KURA)
Roivant Sciences SHS (ROIV)
Bridgebio Pharma (BBIO)
Cytokinetics Com New (CYTK)
Medtronic SHS (MDT)
Orthopediatrics Corp. (KIDS)
Mirum Pharmaceuticals (MIRM)
Guardant Health (GH)
Kelly Svcs Cl A (KELYA)
Abcellera Biologics (ABCL)
Erasca (ERAS)

View all positions for Prosight Management

Top funds holding Privia Health Group

BlackRock
FMR
Vanguard Group
Durable Capital Partners
T. Rowe Price Investment Management
Riverbrige Partners
Wellington Management Company
Bank of New York Mellon
Principal Financial Group
Geode Capital Management
Northern Trust
Franklin Resources
First Light Asset Management
Bellevue Group
Loomis, Sayles and

View all funds holding Privia Health Group